ATE398463T1 - Immunostimulierende zusammnensetzungen die aminoalkyl glucosaminidephosphat und qs-21 enthalten - Google Patents
Immunostimulierende zusammnensetzungen die aminoalkyl glucosaminidephosphat und qs-21 enthaltenInfo
- Publication number
- ATE398463T1 ATE398463T1 AT01925021T AT01925021T ATE398463T1 AT E398463 T1 ATE398463 T1 AT E398463T1 AT 01925021 T AT01925021 T AT 01925021T AT 01925021 T AT01925021 T AT 01925021T AT E398463 T1 ATE398463 T1 AT E398463T1
- Authority
- AT
- Austria
- Prior art keywords
- idephosphate
- immuno
- compositions
- compositions containing
- containing aminoalkyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 title 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 title 1
- 229960002442 glucosamine Drugs 0.000 title 1
- 230000003308 immunostimulating effect Effects 0.000 title 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- -1 aminoalkyl glucosaminide phosphate compound Chemical class 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract 1
- 229930182490 saponin Natural products 0.000 abstract 1
- 150000007949 saponins Chemical class 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19684600P | 2000-04-13 | 2000-04-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE398463T1 true ATE398463T1 (de) | 2008-07-15 |
Family
ID=22727009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01925021T ATE398463T1 (de) | 2000-04-13 | 2001-04-13 | Immunostimulierende zusammnensetzungen die aminoalkyl glucosaminidephosphat und qs-21 enthalten |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1385541B1 (de) |
AT (1) | ATE398463T1 (de) |
AU (1) | AU5162201A (de) |
CA (1) | CA2396762A1 (de) |
DE (1) | DE60134499D1 (de) |
ES (1) | ES2309064T3 (de) |
WO (1) | WO2001078777A2 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US7790856B2 (en) | 1998-04-07 | 2010-09-07 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize beta amyloid peptide |
US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
US7700751B2 (en) | 2000-12-06 | 2010-04-20 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize β-amyloid peptide |
US7030094B2 (en) | 2002-02-04 | 2006-04-18 | Corixa Corporation | Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 |
MY139983A (en) | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
EP1635766A4 (de) * | 2003-06-06 | 2009-09-30 | Agennix Inc | Lactoferrin als adjuvans in krebs-vakzinen |
CA2590337C (en) | 2004-12-15 | 2017-07-11 | Neuralab Limited | Humanized amyloid beta antibodies for use in improving cognition |
WO2007055952A2 (en) * | 2005-11-03 | 2007-05-18 | Wyeth | Process for producing stable hiv th-ctl peptides |
US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
PT2182983E (pt) | 2007-07-27 | 2014-09-01 | Janssen Alzheimer Immunotherap | Tratamento de doenças amiloidogénicas com anticorpos anti-abeta humanizados |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
WO2019175147A1 (en) | 2018-03-12 | 2019-09-19 | Janssen Vaccines & Prevention B.V. | Vaccines against intra-abdominal infections |
EA202192390A1 (ru) | 2019-03-18 | 2021-12-03 | Янссен Фармасьютикалз, Инк. | Биоконъюгаты полисахаридных о-антигенов e.coli, способы их получения и способы их применения |
AU2020240075A1 (en) | 2019-03-18 | 2021-10-14 | Janssen Pharmaceuticals, Inc. | Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof |
AU2020358862A1 (en) | 2019-10-02 | 2022-04-14 | Janssen Vaccines & Prevention B.V. | Staphylococcus peptides and methods of use |
EP4090363B1 (de) | 2020-01-16 | 2024-09-04 | Janssen Pharmaceuticals, Inc. | Fimh-mutante, zusammensetzungen damit und deren verwendung |
WO2022058945A1 (en) | 2020-09-17 | 2022-03-24 | Janssen Pharmaceuticals, Inc. | Multivalent vaccine compositions and uses thereof |
EP4277921A1 (de) | 2021-01-12 | 2023-11-22 | Janssen Pharmaceuticals, Inc. | Fimh-mutanten, zusammensetzungen damit und verwendung davon |
WO2022208430A1 (en) | 2021-04-01 | 2022-10-06 | Janssen Pharmaceuticals, Inc. | Production of e. coli o18 bioconjugates |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9326253D0 (en) * | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
US6113918A (en) * | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
GB9712347D0 (en) * | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
BR9907691B1 (pt) * | 1998-02-05 | 2011-05-31 | derivado de antìgeno e antìgeno da famìlia mage associado a tumor, seqüência de ácido nucléico, codificando os mesmos, seus usos na preparação de vacina, processo para produção de vacina e vacina. |
-
2001
- 2001-04-13 AT AT01925021T patent/ATE398463T1/de not_active IP Right Cessation
- 2001-04-13 AU AU51622/01A patent/AU5162201A/en not_active Withdrawn
- 2001-04-13 ES ES01925021T patent/ES2309064T3/es not_active Expired - Lifetime
- 2001-04-13 DE DE60134499T patent/DE60134499D1/de not_active Expired - Fee Related
- 2001-04-13 WO PCT/US2001/012182 patent/WO2001078777A2/en active Application Filing
- 2001-04-13 CA CA002396762A patent/CA2396762A1/en not_active Abandoned
- 2001-04-13 EP EP01925021A patent/EP1385541B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU5162201A (en) | 2001-10-30 |
ES2309064T3 (es) | 2008-12-16 |
EP1385541B1 (de) | 2008-06-18 |
EP1385541A4 (de) | 2005-12-14 |
WO2001078777A2 (en) | 2001-10-25 |
CA2396762A1 (en) | 2001-10-25 |
DE60134499D1 (de) | 2008-07-31 |
EP1385541A1 (de) | 2004-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE398463T1 (de) | Immunostimulierende zusammnensetzungen die aminoalkyl glucosaminidephosphat und qs-21 enthalten | |
HUP0301815A2 (hu) | Fertżzż és egyéb betegségek kezelésére használható mono- és diszacharid alapú gyógyszerkészítmény és profilaktikus és terápiás kezelés | |
PT1104306E (pt) | Composicoes de cpg e adjuvantes de saponina e seus metodos | |
NO20061912L (no) | Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system | |
MX2008013993A (es) | Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular. | |
CY1110727T1 (el) | Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση | |
DK1187629T3 (da) | Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid | |
MXPA06000619A (es) | Estimulacion sinergistica del sistema inmune usando oligonucleotidos inmunoestimuladores y/o compuestos inmunomeros en conjunto con citocinas y/o agentes quimioterapeuticos o terapia de radiacion. | |
EP1487273A4 (de) | Zusammensetzungen und verfahren für die behandlung von mikroorganismen-infektionen | |
ATE556706T1 (de) | Fettalkohol-arzneimittel-konjugate | |
NO20072526L (no) | Halvfaste C-klasse immunstimulerende oligonukleotider | |
MY137619A (en) | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | |
MY125202A (en) | Vaccine | |
MXPA06005639A (es) | Adyuvante antimicrobiano. | |
GB0123580D0 (en) | Vaccine | |
MX2020008454A (es) | Composicion inmunogenica que comprende antigenos estafilococicos. | |
WO2004024097A8 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2005028496A3 (en) | Vaccine for treatment and prevention of herpes simplex virus infection | |
ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
MY146106A (en) | Antiallergic vaccine composition, method for its preparation and use in the treatment of allergic diseases | |
MX2021014353A (es) | Adyuvantes de vacunas basados en ligandos de receptores tlr. | |
MXPA04007491A (es) | Tratamiento profilactico y terapeutico de infecciones y otras enfermedades con compuestos inmunoefectores. | |
WO2000078800A3 (en) | Combined decorin binding protein and outer surface protein compositions and methods of use | |
MY127452A (en) | Vaccines. | |
AR027738A1 (es) | Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |